More about
Cerebrotendinous Xanthomatosis
News
February 21, 2025
1 min read
Save
FDA approves first treatment for rare lipid storage disease
The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in adults.